Seth Lieblich

Investment Team
San Francisco, CA
[overview]

Seth focuses on 8VC's Bio-IT investment area where he invests, builds and supports companies across areas such as therapeutics, tools, bio-infrastructures and broader applications of biology. He joined 8VC from Amgen’s Business Development technology group, where he was responsible for search & evaluation and transactions for platform technologies across a number of therapeutic and functional areas. Seth was also responsible for strategic academic partnerships across all therapeutic and geographic areas. Prior to Amgen, Seth was at ZS Associates where he led teams engaging in market research, sales force design, and strategy. Prior to ZS Associates, Seth was co-founder and COO of Protomer Technologies, a Pasadena-based biologics startup. Seth received his Ph.D. in Biochemistry and Molecular Biophysics from the California Institute of Technology and holds a B.S and M.S. in Biochemistry from Brandeis University.

[Q&A]